Published in Inf Sci (Ny) on April 29, 2009
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. Elife (2013) 1.12
Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes. PLoS One (2010) 1.08
Characterizing the dynamics of CD4+ T cell priming within a lymph node. J Immunol (2010) 1.07
Bayesian history matching of complex infectious disease models using emulation: a tutorial and a case study on HIV in Uganda. PLoS Comput Biol (2015) 1.05
A multifaceted approach to modeling the immune response in tuberculosis. Wiley Interdiscip Rev Syst Biol Med (2010) 1.03
Modeling of wildlife-associated zoonoses: applications and caveats. Vector Borne Zoonotic Dis (2012) 1.02
Model of colonic inflammation: immune modulatory mechanisms in inflammatory bowel disease. J Theor Biol (2010) 0.99
Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi. Front Microbiol (2012) 0.99
Strategies for efficient numerical implementation of hybrid multi-scale agent-based models to describe biological systems. Cell Mol Bioeng (2015) 0.97
Immature oxidative stress management as a unifying principle in the pathogenesis of necrotizing enterocolitis: insights from an agent-based model. Surg Infect (Larchmt) (2012) 0.95
Tuberculosis: global approaches to a global disease. Curr Opin Biotechnol (2010) 0.94
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models. BMC Syst Biol (2013) 0.92
Agent-based dynamic knowledge representation of Pseudomonas aeruginosa virulence activation in the stressed gut: Towards characterizing host-pathogen interactions in gut-derived sepsis. Theor Biol Med Model (2011) 0.90
Host-pathogen interactions between the human innate immune system and Candida albicans-understanding and modeling defense and evasion strategies. Front Microbiol (2015) 0.89
ENteric Immunity SImulator: a tool for in silico study of gastroenteric infections. IEEE Trans Nanobioscience (2012) 0.87
Towards multiscale modeling of influenza infection. J Theor Biol (2013) 0.87
Can non-lytic CD8+ T cells drive HIV-1 escape? PLoS Pathog (2013) 0.87
Systems biology approaches for understanding cellular mechanisms of immunity in lymph nodes during infection. J Theor Biol (2011) 0.86
A quantitative infection assay for human type I, II, and III interferon antiviral activities. Virol J (2013) 0.85
Viral kinetic modeling: state of the art. J Pharmacokinet Pharmacodyn (2014) 0.85
Prediction of protein solvent accessibility using PSO-SVR with multiple sequence-derived features and weighted sliding window scheme. BioData Min (2015) 0.83
Modelling biological behaviours with the unified modelling language: an immunological case study and critique. J R Soc Interface (2014) 0.83
An agent-based model of cellular dynamics and circadian variability in human endotoxemia. PLoS One (2013) 0.82
A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 1-theoretical model. CPT Pharmacometrics Syst Pharmacol (2014) 0.81
Agent-Based Modeling in Systems Pharmacology. CPT Pharmacometrics Syst Pharmacol (2015) 0.81
Modelling the course of an HIV infection: insights from ecology and evolution. Viruses (2012) 0.80
Using an Agent-Based Model to Examine the Role of Dynamic Bacterial Virulence Potential in the Pathogenesis of Surgical Site Infection. Adv Wound Care (New Rochelle) (2013) 0.79
Sensitivity Analysis of an ENteric Immunity SImulator (ENISI)-Based Model of Immune Responses to Helicobacter pylori Infection. PLoS One (2015) 0.76
A computational model of invasive aspergillosis in the lung and the role of iron. BMC Syst Biol (2016) 0.76
Dosage and Dose Schedule Screening of Drug Combinations in Agent-Based Models Reveals Hidden Synergies. Front Physiol (2016) 0.76
Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity. BMC Infect Dis (2011) 0.76
Mathematical Models for Immunology: Current State of the Art and Future Research Directions. Bull Math Biol (2016) 0.75
Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions. Infect Immun (2016) 0.75
An Agent-Based Model of a Hepatic Inflammatory Response to Salmonella: A Computational Study under a Large Set of Experimental Data. PLoS One (2016) 0.75
Food webs in the human body: linking ecological theory to viral dynamics. PLoS One (2012) 0.75
Automated multi-objective calibration of biological agent-based simulations. J R Soc Interface (2016) 0.75
Mathematics and malaria. Elife (2012) 0.75
Noise propagation through extracellular signaling leads to fluctuations in gene expression. BMC Syst Biol (2013) 0.75
Leukocyte Motility Models Assessed through Simulation and Multi-objective Optimization-Based Model Selection. PLoS Comput Biol (2016) 0.75
Modeling Viral Spread. Annu Rev Virol (2016) 0.75
A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection. Computation (Basel) (2016) 0.75
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (1996) 21.81
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature (2004) 11.14
Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science (2002) 8.94
Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity (2006) 7.22
A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol (2008) 5.11
Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med (2004) 5.08
Simulation of biological cell sorting using a two-dimensional extended Potts model. Phys Rev Lett (1992) 4.85
Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc Natl Acad Sci U S A (2003) 4.22
T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci U S A (2004) 3.99
Simulation of the differential adhesion driven rearrangement of biological cells. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1993) 3.95
Kinetics of influenza A virus infection in humans. J Virol (2006) 3.78
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet (1979) 3.55
Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A (1999) 3.35
In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling. Crit Care Med (2004) 2.60
Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol (2004) 2.58
Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination. J Theor Biol (1979) 2.58
Lymph node topology dictates T cell migration behavior. J Exp Med (2007) 2.19
A multiscale model for avascular tumor growth. Biophys J (2005) 2.14
Key role of local regulation in chemosensing revealed by a new molecular interaction-based modeling method. PLoS Comput Biol (2006) 2.13
Architecture for an artificial immune system. Evol Comput (2000) 2.03
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine (1997) 1.95
Spatial heterogeneity in epidemic models. J Theor Biol (1996) 1.92
A computer model of cellular interactions in the immune system. Immunol Today (1992) 1.76
A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J (2007) 1.74
Size and connectivity as emergent properties of a developing immune network. J Theor Biol (1991) 1.69
Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor Biol (2006) 1.66
Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity (2004) 1.66
Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials. Shock (2001) 1.62
Mathematical model of antiviral immune response. III. Influenza A virus infection. J Theor Biol (1994) 1.62
Reproductive pair correlations and the clustering of organisms. Nature (2001) 1.61
Dynamics of HIV infection: a cellular automata approach. Phys Rev Lett (2001) 1.60
Spatial heterogeneity and the persistence of infectious diseases. J Theor Biol (2004) 1.58
A simple cellular automaton model for influenza A viral infections. J Theor Biol (2005) 1.54
Predictability and preparedness in influenza control. Science (2006) 1.49
Emergent dynamics of thymocyte development and lineage determination. PLoS Comput Biol (2006) 1.49
Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation. Genome Res (2003) 1.48
Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics (2005) 1.42
Toward a multiscale model of antigen presentation in immunity. Immunol Rev (2007) 1.42
A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. I. Viral characteristics and polarized responses. Vaccine (2000) 1.36
Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J (2004) 1.34
An extended vision for dynamic high-resolution intravital immune imaging. Semin Immunol (2005) 1.32
A computerized model for the self-non-self discrimination at the level of the T(h) (Th genesis). II. The behavior of the system upon encounter with non-self antigens. Int Immunol (2003) 1.31
The IUPS human Physiome Project. Pflugers Arch (2002) 1.25
Characterizing T cell movement within lymph nodes in the absence of antigen. J Immunol (2007) 1.24
Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model. J Theor Biol (2002) 1.18
Design and implementation of an immune system simulator. Comput Biol Med (2001) 1.16
Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity. Biotechnol Bioeng (2005) 1.15
An artificial immune system approach with secondary response for misbehavior detection in mobile ad hoc networks. IEEE Trans Neural Netw (2005) 1.11
Computer immunology. Immunol Rev (2007) 1.11
A computerized model for the self-non-self discrimination at the level of the T(h) (Th genesis). I. The origin of 'primer' effector T(h) cells. Int Immunol (2002) 1.09
Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur J Immunol (1996) 1.07
Concepts for developing a collaborative in silico model of the acute inflammatory response using agent-based modeling. J Crit Care (2006) 1.04
Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J Virol (2002) 0.99
Modelling vaccination schedules for a cancer immunoprevention vaccine. Immunome Res (2005) 0.99
Modelling dynamics of the type I interferon response to in vitro viral infection. J R Soc Interface (2006) 0.99
A model for simulating cognate recognition and response in the immune system. J Theor Biol (1992) 0.99
A virtual look at Epstein-Barr virus infection: simulation mechanism. J Theor Biol (2008) 0.97
Spatiotemporal dynamics of HIV propagation. J Theor Biol (2002) 0.96
Probing the effects of the well-mixed assumption on viral infection dynamics. J Theor Biol (2006) 0.95
Quantifying viral propagation in vitro: toward a method for characterization of complex phenotypes. Biotechnol Prog (2001) 0.93
Spatial models of virus-immune dynamics. J Theor Biol (2004) 0.93
Interpreting two-photon imaging data of lymphocyte motility. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.93
Modeling intercellular interactions in early Mycobacterium infection. Bull Math Biol (2006) 0.90
A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog (2007) 0.90
An enhanced agent based model of the immune system response. Cell Immunol (2007) 0.90
A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors. J Immunol (1997) 0.89
Simple scaling laws for influenza A rise time, duration, and severity. J Theor Biol (2007) 0.89
Robustness and fragility in immunosenescence. PLoS Comput Biol (2006) 0.86
Cellular automata-based modeling program: synthetic immune system. Immunol Rev (2007) 0.84
Homeostasis of peripheral immune effectors. Bull Math Biol (2004) 0.79
Using lazy evaluation to simulate realistic-size repertoires in models of the immune system. Bull Math Biol (1998) 0.77
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med (2009) 6.22
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med (2009) 4.79
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol (2003) 4.12
Kinetics of influenza A virus infection in humans. J Virol (2006) 3.78
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog (2010) 3.68
Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol (2007) 3.24
Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One (2010) 3.02
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A (2014) 2.95
Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci Transl Med (2010) 2.82
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A (2013) 2.79
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature (2004) 2.74
Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin. Hepatology (2003) 2.50
Modeling sequence evolution in acute HIV-1 infection. J Theor Biol (2009) 2.32
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A (2012) 2.27
The complexity of complexes in signal transduction. Biotechnol Bioeng (2003) 2.20
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest (2012) 2.05
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. J Acquir Immune Defic Syndr (2004) 2.05
Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J Immunol (2003) 2.03
Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol (2010) 2.02
Kinetics of hepatitis C virus reinfection after liver transplantation. Liver Transpl (2006) 2.01
Triphasic decline of hepatitis C virus RNA during antiviral therapy. Hepatology (2007) 2.00
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog (2010) 1.99
Determining the relative efficacy of highly active antiretroviral therapy. J Infect Dis (2003) 1.90
Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy. J Theor Biol (2007) 1.89
Designing a genome-based HIV incidence assay with high sensitivity and specificity. AIDS (2011) 1.88
Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration. Hepatology (2011) 1.87
Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J Immunol (2003) 1.87
In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci U S A (2002) 1.82
Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J Virol (2010) 1.80
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy. PLoS Comput Biol (2009) 1.78
Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J Virol (2004) 1.77
Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol (2009) 1.76
Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin. J Hepatol (2007) 1.74
ON IDENTIFIABILITY OF NONLINEAR ODE MODELS AND APPLICATIONS IN VIRAL DYNAMICS. SIAM Rev Soc Ind Appl Math (2011) 1.69
Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders. Hepatology (2006) 1.69
Polyspecificity of T cell and B cell receptor recognition. Semin Immunol (2007) 1.68
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut (2013) 1.63
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog (2012) 1.61
Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus. Eur J Immunol (2005) 1.60
Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J Virol (2011) 1.57
Parameter identifiability and estimation of HIV/AIDS dynamic models. Bull Math Biol (2008) 1.56
Drug resistance and influenza pandemics. Lancet (2002) 1.55
Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 1.54
Estimating lymphocyte division and death rates from CFSE data. Bull Math Biol (2006) 1.53
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance. J Acquir Immune Defic Syndr (2005) 1.52
Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis. J Virol (2008) 1.51
Viral blip dynamics during highly active antiretroviral therapy. J Virol (2003) 1.51
Modeling amantadine treatment of influenza A virus in vitro. J Theor Biol (2008) 1.51
Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J Virol (2008) 1.49
Modeling HIV persistence, the latent reservoir, and viral blips. J Theor Biol (2009) 1.49
Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc Natl Acad Sci U S A (2007) 1.48
Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology (2005) 1.47
HIV-1 infection and low steady state viral loads. Bull Math Biol (2002) 1.46
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J Infect Dis (2002) 1.45
Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. BMC Bioinformatics (2010) 1.45
Multiplicity of human immunodeficiency virus infections in lymphoid tissue. J Virol (2004) 1.43
Complete genetic linkage can subvert natural selection. Proc Natl Acad Sci U S A (2007) 1.42
Mathematical analysis of delay differential equation models of HIV-1 infection. Math Biosci (2002) 1.41
Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay. J Virol (2006) 1.41
Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression. PLoS Comput Biol (2008) 1.39
Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay. J Theor Biol (2004) 1.39
HIV dynamics with multiple infections of target cells. Proc Natl Acad Sci U S A (2005) 1.36
Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A (2011) 1.36
Quantifying T lymphocyte turnover. J Theor Biol (2013) 1.35
Viral and latent reservoir persistence in HIV-1-infected patients on therapy. PLoS Comput Biol (2006) 1.35
Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy. J Virol (2006) 1.31
Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. PLoS Pathog (2012) 1.30
Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals. AIDS (2003) 1.30
Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy. J Hepatol (2002) 1.30
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J Virol (2011) 1.28
Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing. PLoS Pathog (2012) 1.28
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection. J Infect Dis (2003) 1.27
Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput Biol (2012) 1.26
Characterizing T cell movement within lymph nodes in the absence of antigen. J Immunol (2007) 1.24
Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antivir Ther (2004) 1.23
Influence of peak viral load on the extent of CD4+ T-cell depletion in simian HIV infection. J Acquir Immune Defic Syndr (2006) 1.23
Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon. J Virol (2009) 1.23
Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology (2013) 1.23
Determining thymic output quantitatively: using models to interpret experimental T-cell receptor excision circle (TREC) data. Immunol Rev (2007) 1.23
Modeling HCV kinetics under therapy using PK and PD information. Expert Opin Drug Metab Toxicol (2009) 1.22
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses? J Antimicrob Chemother (2008) 1.21
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J Virol (2006) 1.21
How antigen quantity and quality determine T-cell decisions in lymphoid tissue. Mol Cell Biol (2008) 1.20
Dynamics of hepatitis B virus infection. Microbes Infect (2002) 1.20
A stochastic model of cytotoxic T cell responses. J Theor Biol (2004) 1.20
The role of cells refractory to productive infection in acute hepatitis B viral dynamics. Proc Natl Acad Sci U S A (2007) 1.19
Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip Rev Syst Biol Med (2010) 1.18
Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b. Semin Liver Dis (2003) 1.18
Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology (2002) 1.18
Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments. Bull Math Biol (2008) 1.17
Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog (2013) 1.16
Stochastic theory of early viral infection: continuous versus burst production of virions. PLoS Comput Biol (2011) 1.15
Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLoS Comput Biol (2010) 1.15
Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus. J Virol (2007) 1.15
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy. Math Biosci (2004) 1.14
Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity. J Virol (2010) 1.14